학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 157건 | 목록 1~10
Academic Journal
Siqueira IB; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49107-230 Sergipe, Brazil.; de Oliveira YLM; Department of Morphology, Federal University of Sergipe, São Cristóvão, 49107-230 Sergipe, Brazil.; Caron BO; Department of Agronomic and Environmental Sciences, Federal University of Santa Maria, Frederico Westphalen, 98400-000 Rio Grande do Sul, Brazil.; Schmidt D; Department of Agronomic and Environmental Sciences, Federal University of Santa Maria, Frederico Westphalen, 98400-000 Rio Grande do Sul, Brazil.; Silva ARST; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49107-230 Sergipe, Brazil.; Jain S; Department of Morphology, Federal University of Sergipe, São Cristóvão, 49107-230 Sergipe, Brazil.; de Souza JDS; Maceio University Center (UNIMA/Afya), Maceió, 57035-240 Alagoas, Brazil.; Sarmento VHV; Department of Chemistry, Federal University of Sergipe, Itabaiana, 49500-000 Sergipe, Brazil.; Alves SM; Department of Chemistry, Federal University of Sergipe, Itabaiana, 49500-000 Sergipe, Brazil.; Rott MB; Laboratory of Protozoology, Department of Microbiology, Immunology and Parasitology, Institute of Basic Health Sciences, Federal University of Rio Grande Do Sul, Porto Alegre, 90050-170 Rio Grande do Sul, Brazil.; Correa CB; Department of Morphology, Federal University of Sergipe, São Cristóvão, 49107-230 Sergipe, Brazil.; Scher R; Department of Morphology, Federal University of Sergipe, São Cristóvão, 49107-230 Sergipe, Brazil.; Barbosa AAT; Department of Morphology, Federal University of Sergipe, São Cristóvão, 49107-230 Sergipe, Brazil.; Dolabella SS; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, 49107-230 Sergipe, Brazil.; Department of Morphology, Federal University of Sergipe, São Cristóvão, 49107-230 Sergipe, Brazil.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9706280 Publication Model: Print Cited Medium: Internet ISSN: 1365-2672 (Electronic) Linking ISSN: 13645072 NLM ISO Abbreviation: J Appl Microbiol Subsets: MEDLINE
Academic Journal
Konnerth D; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany. dinah.konnerth@med.uni-muenchen.de.; Gaasch A; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Westphalen CB; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center (CCC Munich LMU), University Hospital, LMU Munich, Munich, Germany.; Heinrich K; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Niyazi M; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.; Eze C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Rogowski P; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Marschner S; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; Zinn A; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; Corradini S; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Schönecker S; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE
Academic Journal
Westphalen CB; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich; German Cancer Consortium (DKTK), partner site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: education@esmo.org.; Martins-Branco D; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Beal JR; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.; Cardone C; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori- IRCCS-Fondazione G. Pascale, Naples, Italy.; Coleman N; School of Medicine, Trinity College Dublin, Dublin; Medical Oncology Department, St. James's Hospital, Dublin; Trinity St. James's Cancer Institute, Dublin, Ireland.; Schram AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City; Weill Cornell Medical College, New York City.; Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham; Duke Cancer Institute, Duke University, Durham, USA.; Michiels S; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif, France.; Yap C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.; André F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre.; Bibeau F; Service d'Anatomie Pathologique, CHU Besançon, Université de Bourgogne Franche-Comté, Besançon, France.; Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Kummar S; Division of Hematology and Medical Oncology, Department of Medicine, Knight Cancer Institute, Oregon Health and Science University, Portland.; Kurzrock R; Department of Medicine, Medical College of Wisconsin Cancer Center, Milwaukee, USA.; Limaye S; Medical & Precision Oncology, Sir H. N. Reliance Foundation Hospital & Research Centre, Mumbai, India.; Loges S; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), German Center for Lung Research (DZL), German Cancer Consortium (DKTK), Heidelberg, Germany.; Marabelle A; Drug Development Department (DITEP) and Laboratory for Translational Research in Immunotherapy (LRTI), Gustave Roussy, INSERM U1015 & CIC1428, Université Paris-Saclay, Villejuif, France.; Marchió C; Department of Medical Sciences, University of Turin, Turin; Division of Pathology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Rodon J; Department of Investigational Cancer Therapeutics, UT MD Anderson, Houston, USA.; Spanic T; Europa Donna Slovenia, Ljubljana, Slovenia.; Pentheroudakis G; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Subbiah V; Early-Phase Drug Development, Sarah Cannon Research Institute (SCRI), Nashville, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
van de Haar J; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam.; Roepman P; Medical Department, Hartwig Medical Foundation, Amsterdam, The Netherlands.; Andre F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre, France.; Balmaña J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.; Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid, Spain.; Chakravarty D; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.; Curigliano G; Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.; Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona; University of Vic-Central University of Catalonia, Vic, Spain; Oncoclínicas, São Paulo, Brazil.; Horak P; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Italiano A; Early Phase Trials and Sarcoma Units, Institut Bergonie, Bordeaux; DITEP, Gustave Roussy, Villejuif; Faculty of Medicine, University of Bordeaux, Bordeaux, France.; Marchiò C; Department of Medical Sciences, University of Turin, Turin; Division of Pathology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Pritchard CC; Department of Laboratory Medicine and Pathology, Brotman Baty Institute for Precision Medicine, University of Washington, Seattle.; Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, USA.; Russnes HEG; Department of Pathology, Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Sirohi B; Department of Medical Oncology, Vedanta Medical Research Foundation (BALCO Medical Centre), Raipur, India.; Sosinsky A; Genomics England, London, UK.; Spanic T; Europa Donna Slovenia, Ljubljana, Slovenia.; Turnbull C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London; The Royal Marsden NHS Foundation Trust, London, UK.; Van Allen E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, USA; Harvard Medical School, Harvard University, Boston, USA.; Westphalen CB; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Tamborero D; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Electronic address: education@esmo.org.; Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona. Electronic address: education@esmo.org.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Mosele MF; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Westphalen CB; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich.; Stenzinger A; Institute of Pathology, University Hospital Heidelberg and Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Barlesi F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre.; Bayle A; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre; Drug Development Department (DITEP), Gustave Roussy, Villejuif; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif.; Bièche I; Department of Genetics, Institut Curie, INSERM U1016, Université Paris Cité, Paris, France.; Bonastre J; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif.; Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid.; Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona; University of Vic-Central University of Catalonia, Vic, Spain; Oncoclínicas, São Paulo, Brazil.; Krämer A; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.; Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.; Michiels S; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif.; Miller R; Department of Medical Oncology, University College London, London; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.; Normanno N; Scientific Directorate, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Reis-Filho J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York.; Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Robson M; Breast Medicine and Clinical Genetics Services, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.; Rouleau E; Tumor Genetics Service, Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; Scarpa A; Section of Pathology, Department of Diagnostics and Public Health, University of Verona-School of Medicine, Verona, Italy.; Serrano C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.; Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.; André F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre. Electronic address: education@esmo.org.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Mansour N; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Heinrich K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; Zhang D; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK partner site Munich), Heidelberg, Germany.; Winkelmann M; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Ingenerf M; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Gold L; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Klambauer K; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Rudelius M; Institute of Pathology, Ludwig-Maximilians-Universität Munich, Munich, Germany.; Klauschen F; Institute of Pathology, Ludwig-Maximilians-Universität Munich, Munich, Germany.; Bergwelt-Baildon MV; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK partner site Munich), Heidelberg, Germany.; Ricke J; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Heinemann V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; Westphalen CB; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany.; Kunz WG; Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. wolfgang.kunz@med.lmu.de.; Comprehensive Cancer Center München-LMU (CCCM LMU), LMU Munich, Munich, Germany. wolfgang.kunz@med.lmu.de.
Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330 (Electronic) Linking ISSN: 14707330 NLM ISO Abbreviation: Cancer Imaging Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Ambrosini M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Rousseau B; Memorial Sloan Kettering Cancer Center, New York, USA.; Manca P; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Memorial Sloan Kettering Cancer Center, New York, USA.; Artz O; Memorial Sloan Kettering Cancer Center, New York, USA.; Marabelle A; Department of Therapeutic Innovation and Phase 1 clinical trials, Inserm, Gustave Roussy, Université Paris Saclay, Villejuif.; André T; Sorbonne Université and Department of Medical Oncology, Hôpital Saint Antoine, Paris, France.; Maddalena G; Istituto Oncologico Veneto, IRCCS, Padua, Italy.; Mazzoli G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Intini R; Istituto Oncologico Veneto, IRCCS, Padua, Italy.; Cohen R; Sorbonne Université and Department of Medical Oncology, Hôpital Saint Antoine, Paris, France.; Cercek A; Memorial Sloan Kettering Cancer Center, New York, USA.; Segal NH; Memorial Sloan Kettering Cancer Center, New York, USA.; Saltz L; Memorial Sloan Kettering Cancer Center, New York, USA.; Varghese AM; Memorial Sloan Kettering Cancer Center, New York, USA.; Yaeger R; Memorial Sloan Kettering Cancer Center, New York, USA.; Nusrat M; Memorial Sloan Kettering Cancer Center, New York, USA.; Goldberg Z; Memorial Sloan Kettering Cancer Center, New York, USA.; Ku GY; Memorial Sloan Kettering Cancer Center, New York, USA.; El Dika I; Memorial Sloan Kettering Cancer Center, New York, USA.; Margalit O; Oncology Department, Sheba Medical Center and Tel-Aviv University Medicine Faculty, Tel-Aviv.; Grinshpun A; Sharett Institute of Oncology, Hadassah Medical Center, and Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Murtaza Kasi P; Weill Cornell Medicine, New York, NY.; Schilsky R; University of Chicago, Chicago, USA.; Lutfi A; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City.; Shacham-Shmueli E; Oncology Department, Sheba Medical Center and Tel-Aviv University Medicine Faculty, Tel-Aviv.; Khan Afghan M; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City.; Weiss L; Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, University Hospital, Ludwig Maximilian University of Munich, Munich; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Westphalen CB; Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, University Hospital, Ludwig Maximilian University of Munich, Munich; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Conca V; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Decker B; Foundation Medicine, Cambridge, USA.; Randon G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Elez E; Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Fakih M; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte.; Schrock AB; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Jayachandran P; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles.; Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Lonardi S; Istituto Oncologico Veneto, IRCCS, Padua, Italy.; Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: filippo.pietrantonio@istitutotumori.mi.it.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Westphalen CB
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어